On June 25, 2025, Cocrystal Pharma, Inc. held its Annual Meeting where stockholders voted to elect six board members, ratify the accounting firm, and approve a new equity plan, with all proposals passing. Key voting results included 4,440,602 votes in favor of board nominee Fred Hassan and 3,764,418 votes for the equity plan approval.